Novartis already received FDA approval of ITVISMA as a gene therapy for the treatment of patients with SMA. Read why NVS ...
A new study reveals experimental drug XL20 crosses the blood-brain barrier to stop toxic TDP-43 clumping in ALS.
An experimental drug that targets the TDP-43 protein offers hope for treating Amyotrophic Lateral Sclerosis (ALS), a condition that still lacks both a treatment and a cure. ALS received widespread ...
PRECISE-HD Study. Focused on further evaluating the efficacy and safety of pridopidine, an investigational medicinal product ...
Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive ...
Executive Summary The SAMANSIC Protocol represents a paradigm-shifting integration of geophysical sensing, sovereign ...
Morning Overview on MSN
A brain protein that helps neurons talk may be helping Alzheimer’s spread, Utah scientists found
A protein that neurons rely on to share genetic messages with each other also packages and spreads toxic tau, the misfolded ...
The speed at which a cell produces proteins is a decisive factor in determining whether it divides, specializes or retains ...
Researchers from University of Arizona present a new therapeutic target to shield nerve cells from the damage of ALS.
Inherited retinal degenerations are a diverse group of genetic disorders that result in progressive vision loss. Advances in ...
Integrating case counts with genomic sequences quantifies real-time transmission advantages of viral variants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results